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Autophagy, initially viewed as a conserved bulk-degradation mechanism, has emerged
as a central player in a multitude of immune functions. Autophagy is important in host
defense against intracellular and extracellular pathogens, metabolic syndromes, immune
cell homeostasis, antigen processing and presentation, and maintenance of tolerance.
The observation that the above processes are implicated in triggering or exacerbating
autoimmunity raises the possibility that autophagy is involved in mediating autoimmune
processes, either directly or as a consequence of innate or adaptive functions mediated
by the pathway. Genome-wide association studies have shown association between sin-
gle nucleotide polymorphisms (SNPs) in autophagy related gene 5 (Atg5), and Atg16l1
with susceptibility to systemic lupus erythematosus (SLE) and Crohn’s disease, respec-
tively. Enhanced expression of Atg5 was also reported in blood of mice with experimental
autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), and in
T cells isolated from blood or brain tissues from patients with active relapse of MS. This
review explores the roles of autophagy pathway in the innate and adaptive immune sys-
tems on regulating or mediating the onset, progression, or exacerbation of autoimmune
processes.
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The autophagy pathway, an evolutionary conserved mechanism,
starts with the development of an isolation membrane within
the cell that engulfs damaged organelles, misfolded proteins
or pathogens, and eventually develops into an autophagosome.
The autophagosomes, in turn, fuse with lysosomes to form the
autophagolysosomes where the actual degradation of the sub-
strates takes place (Levine et al., 2011). For the individual cell,
the autophagy pathway is important not only to get rid of foreign
or unwanted materials but also for efficient energy recycling dur-
ing periods of stress. For the whole organism, the immune and
physiological consequences of aberration of the autophagy path-
way are much more profound. The immune system, responsible
for surveillance and communication between different organs and
cells types, is one such system in which the role of autophagy
and the consequences of defects in autophagy go far beyond the
degradative role of the pathway (Deretic, 2012a). Figure 1 shows
potential roles of the autophagy pathway in the adaptive and innate
immune systems that might modulate the onset and outcome of
an autoimmune disease.
AUTOPHAGY, THE ADAPTIVE IMMUNE SYSTEM AND
AUTOIMMUNITY
Autophagy plays important roles in both innate and adaptive
immunity. Because there have been several excellent reviews on
this topic (Munz, 2009; Sumpter and Levine, 2010; Kuballa et al.,
2012; Randow and Munz, 2012), we will only discuss brief aspects
of these roles as they might pertain to autoimmunity. Autophagy
is essential for survival and homeostasis of lymphocytes and there
exist at least two broad stages where autophagy might affect
the adaptive immune cells. As the development of lymphocyte
is a complex process involving inputs from other cells, both
lymphocyte-intrinsic and extrinsic defects in autophagy might
affect development and/or maturation of lymphocytes.
AUTOPHAGY IN LYMPHOCYTE DEVELOPMENT
T cell development in the thymus undergoes positive and nega-
tive selections, processes in which extrinsic inputs from thymic
epithelial cells (TECs) play a major role in shaping the T cell
repertoire. TECs show high levels of constitutive autophagy essen-
tial for proper display of MHC-antigen complex on their surface
(Mizushima et al., 2004; Kasai et al., 2009), thereby facilitat-
ing appropriate T cell selection. Mice with Atg5 deficiency in
TECs showed severely impaired central tolerance and autoimmune
organ destruction, suggesting that autophagy-mediated display of
MHC-antigen complex on surface of TECs is essential for proper
T cell development (Nedjic et al., 2008). Autophagy deficiency in
the TECs impaired both positive and negative selection mech-
anisms resulting into autoimmunity and it was proposed that
autophagy-dependent display in the peripheral tissue needed to
be counterbalanced by a similar tolerogenic mechanism in the
thymus in order to prevent such autoimmune processes (Nedjic
et al., 2008). Further, a recent report demonstrated the require-
ment of autophagy in TECs for loading endogenous antigens onto
MHC-II and that this process was essential for negative selections
of CD4 T cells (Aichinger et al., 2013). Because both DCs and TECs
might be important in differentiation of regulatory T cells (Tregs)
(Wirnsberger et al., 2009; Hinterberger et al., 2010), this report
suggested that autophagy might be important in differentiation
of Tregs (Aichinger et al., 2013). As Tregs are among the major
players controlling autoimmunity (La Cava, 2009), this might
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FIGURE 1 | Potential roles of autophagy in the adaptive and innate
immune systems to mediate autoimmunity.The known roles of autophagy
in the contributing processes are highlighted and the broken lines show
potential contributions toward autoimmunity. A question mark denotes the
possibility that the autophagy pathway might modulate autoimmune diseases
through these processes. TECs, thymic epithelial cells.
be another potential link between autophagy and autoimmune
diseases.
Fetal liver chimera and conditional knock-out studies have
shown that T cell development remained normal in mice lacking
Atg5 in T cells but peripheral T cell compartment showed reduc-
tion in numbers, particularly in CD8 T cells (Pua et al., 2007).
These results were attributed to the pro-survival role of autophagy
in mature T cells. Studies showed considerable interaction between
the autophagy and apoptotic pathways (Maiuri et al., 2007). Atg3,
5, or 7 -deficient mature T cells showed defective Endoplasmic
reticulum (ER) homeostasis and mitochondrial clearance and,
consequently, an elevated levels of ROS, which might serve as one
of the potential links between the autophagy and apoptotic path-
ways (Pua et al., 2007; Jia and He, 2011; Jia et al., 2011). However,
increased levels of mitochondria were observed in Atg7−/− but
not in Atg5−/− thymocytes at the single positive stage (Pua et al.,
2009). A possible explanation could be different stages or extent of
involvement of these proteins in mitochondrial clearance. These
findings potentially brings another layer of complexity into focus,
namely autophagy-independent effect of various Atg.
In contrast to T cells, autophagy in B cells plays a very important
role in development and the requirement of Atg5 has been found
to be highly stage-specific, with a defective pro- to pre-B cell transi-
tion in B cell-specific Atg5−/− knock-out mice. In these mice, the
levels of pre and immature B cells, along with peritoneal B1 cells
were reduced to a great extent. This finding was also attributed to
a role of autophagy in maintaining B cell survival (Miller et al.,
2008).
AUTOPHAGY IN LYMPHOCYTE FUNCTIONS
Autophagy induction in response to starvation and TCR stim-
ulation has been observed in mouse T cells (Pua et al., 2007)
and in cultured human T cells during aging (Gerland et al.,
2004) and in HIV infection (Espert et al., 2006). Atg5-deficient
T cells showed reduced proliferation upon both TCR and PMA-
ionomycin stimulation (Pua et al., 2007). This finding highlights
potentially different roles of autophagy in naïve versus activated
T cells. Most studies involving autophagy in T cells focused on
roles of autophagy in cell survival and found autophagy to be a
pro-survival mechanism (Pua et al., 2007). However, some studies
have also suggested that autophagy might be required for T cell
death (Espert et al., 2006; Bell et al., 2008). Uninfected lympho-
cytes undergo autophagy-mediated cell death upon engagement
of the receptor CXCR4 by HIV envelop glycoprotein (Espert et al.,
2006). Another study has also shown that autophagy could be
an important cell death machinery in T cells lacking caspase-8
or Fas-associated death domain (FADD) activity, thereby raising
the possibility that interaction between autophagy and apoptosis
might be context dependent (Bell et al., 2008). It is possible that,
in activated T cells, autophagy plays different roles compared to
naïve cells and might be involved in activation-induced cell death
following T cell proliferation in immune response.
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Recent findings suggest that autophagy might affect overall T
cell functions under different conditions of polarization and acti-
vation. Rapamycin, an mTOR inhibitor and inducer of autophagy,
has been found to promote T cell memory when administered in
low doses, although it is not clear if this effect is mediated by
autophagy (Araki et al., 2009). Moreover, low dose rapamycin
exacerbated autoimmune experimental uveitis, and this action
of rapamycin was thought to be mediated by autophagy (Zhang
et al., 2012). Interestingly, expression of Atg5 has been shown to
correlate with severity of experimental autoimmune encephali-
tis (EAE), a mouse model of multiple sclerosis (MS), and to
be increased in T cells of MS patients during relapses (Alirezaei
et al., 2009), which can worsen by prolonged autoreactive T cell
survival. EAE is considered predominantly a CD4 mediated dis-
ease and further studies are required to dissect how autophagy in
T cells influences the onset or progression of autoimmune dis-
eases in animal models and if these roles of autophagy are also
dependent on cell survival. These studies can develop in vivo
models in which the roles of autophagy in CD4 or CD8 cells
could be studied independent to its pro- or anti-survival func-
tions, particularly in the context of an infection or autoimmune
disease.
In mature B cells, BCR signal can lead to B cell activation or
apoptosis, depending on the context. Autophagy is involved in
both processes, with BCR-activation-mediated cell death being
associated with extensive autophagosome formation (Watanabe
et al., 2008). B cells are capable of antigen processing follow-
ing BCR ligation and autophagy might be involved in such
process (Watanabe et al., 2008). BCR signaling recruits TLR-9 to
autophagosome for further interaction with its ligand (Chaturvedi
et al., 2008). Systemic lupus erythematosus (SLE) is perhaps the
most studied autoimmune disease with respect to the roles of
autophagy in autoimmune processes (Pierdominici et al., 2012).
There are a number of potential mechanisms by which autophagy
might influence the pathogenesis of SLE, modulating both the
adaptive and innate immune system. As B cells represent a major
player in SLE, in which they act by both antibody-dependent
and antibody-independent mechanisms, autophagy-mediated B
cell modulation might directly influence the pathophysiology
of SLE.
AUTOPHAGY, THE INNATE IMMUNE SYSTEM AND
AUTOIMMUNITY
Autoimmunity results from uncontrolled action of the adaptive
immune cells, however, activation of the adaptive system depends
on the innate immune cells and the innate immune system is per-
haps the most extensively studied component with respect to the
role of autophagy in shaping the organization and functions of the
system (Deretic, 2012b).
The innate immune functions can be broadly categorized into
four overlapping stages, migration, recognition and phagocyto-
sis, antigen processing and presentation, and cytokine secretion.
Autophagy plays particularly important roles in the last three
stages, thereby not only shaping the innate immune response
but also influencing the activation of the adaptive immune
compartment.
LEVEL ONE: PHAGOCYTOSIS, AUTOPHAGY, AND
AUTOIMMUNITY
The role of autophagy in innate immunity is best characterized
with respect to pathogen elimination. Both pathogen recogni-
tion and intracellular killing can be controlled by autophagy. The
autophagy pathway interacts extensively with a number of pat-
tern recognition receptors (PRR) and PRR activation in a wide
variety of cases has been shown to induce autophagy (Tang et al.,
2012). However, recent evidences suggest that this process might
also extend beyond pathogen control.
Phagocytosis can be viewed as a coordinated interaction
between two different kinds of players, a predator that engulfs
the materials to be cleared, macrophages being the professional
phagocytes in the body, and prey to be engulfed such as a pathogen,
foreign materials, or dead cells. Autophagy has been found to
be an essential process for dead cell clearance. Apoptotic cells
release lysophosphatidylcholine (LPC) as a “come-get-me” signal
for phagocytes and upregulate phosphatidylserine (PS) as an “eat
me” signal on their surface. Autophagy genes are essential for effi-
cient release of LPC and in absence of autophagy, apoptotic cells
fail to express PS properly on their surface (Qu et al., 2007).
On the other hand, proteins involved in autophagy pathway,
such as LC3-II (Microtubule-associated protein 1 light chain 3
alpha), Beclin 1, and VPS34, are recruited to phagosomes following
phagocytosis of particles containing TLR ligands by macrophages
(Sanjuan et al., 2007). LC3-associated phagocytosis, a process dis-
tinct from classical autophagy, has also been found to be necessary
to carry out efficient dead cell clearance (Martinez et al., 2011)
and defects in expression of MARCO (macrophage receptor with
collagenous structure), a receptor involved in dead cell clearance,
has been shown to result into reduced dead cell clearance and SLE
in mice (Rogers et al., 2009). Thus, an absence of autophagy or
autophagic proteins might result into defective clearance of apop-
totic cells. As defects in apoptotic cell clearance have been linked to
a number of autoimmune diseases, such as SLE, it is possible that
autophagy might modulate the susceptibility to autoimmunity.
It should also be noted that autophagy induction in
macrophages has been shown to affect phagocytosis of pathogens,
though the reports are conflicting, indicating both increase and
decrease in phagocytosis following induction of autophagy (Mar-
tinet et al., 2009; Lima et al., 2011). A number of autoimmune
diseases are precipitated or exacerbated following infection (Kiv-
ity et al., 2009). It would be important to determine if changes in
apoptotic cell clearance occur following infection-induced modu-
lation in autophagy, which in turn could modulate the induction
or exacerbation of autoimmune processes.
LEVEL TWO: ANTIGEN PRESENTATION, AUTOPHAGY, AND
AUTOIMMUNITY
The classic definition of antigen presentation is that extracellular
antigens are presented in the context of class II MHC follow-
ing endocytosis and phagolysosomal degradation (Gannage and
Munz, 2010). Recent evidence suggests that this process depends
on the autophagy pathway. Characterization of the MHC-II lig-
ands, called ligandome, in a human B lymphoblastoid cell line
showed that peptides from intracellular sources are presented on
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MHC-II and starvation-induced autophagy enhanced this process
(Dengjel et al., 2005). Further, autophagosomes colocalize with
MHC-II loading compartments in two important antigen pre-
senting cells (APCs) that shape up the entire adaptive immune
repertoire. These cells are TECs, that shape up the T cell reper-
toire, and the dendritic cells (DC) that act as the professional APCs
(Schmid and Munz, 2007; Schmid et al., 2007). Mice with DCs
lacking Atg5 succumbed to HSV-2 infection and showed defective
CD4 T cell priming. These DCs showed defective antigen presen-
tation resulting from a profound defect in processing and delivery
of antigens containing TLR ligands to MHC-II compartment and
delayed phagolysosomal fusion and degradation of the antigens
(Lee et al., 2010). Autophagy induction in bone-marrow DCs also
enhanced presentation of mycobacterial antigen and mice immu-
nized with rapamycin-treated DCs showed stronger T cell response
upon challenge with Mtb (Jagannath et al., 2009). Autophagy in
APCs is involved in presentation of citrullinated peptide, a hall-
mark of rheumatoid arthritis, in context of class II MHC (Ireland
and Unanue, 2011). It also has been suggested that autophagy may
be involved in class I antigen presentation to CD8 T cells, partic-
ularly in context of viral infection (English et al., 2009; Uhl et al.,
2009).
Dendritic cell-mediated antigen presentation in the context of
MHC-II is perhaps an area where the role of autophagy could
directly influence autoimmune diseases. Activation of the adap-
tive immune cells, the major players in most autoimmune dis-
eases, depends primarily on DC-mediated antigen presentation.
Genome-wide association studies have identified Atg5 as one of
the susceptibility loci in SLE (Harley et al., 2008; Gateva et al.,
2009; Han et al., 2009; Zhou et al., 2011a), though the functional
significance of this finding is yet to be established. A number
of possibilities have been raised ranging from increased survival
of pathogenic T cells to defects in apoptotic cell clearance and
several autophagy modulators are currently in clinical trials for
SLE (Pierdominici et al., 2012). It is interesting to note that the
PRDM1-ATG5 intergenic region has also been associated with sus-
ceptibility to rheumatoid arthritis (Raychaudhuri et al., 2009) and
a common role of the autophagy pathway in different autoim-
mune diseases has been proposed (Zhou et al., 2011a). Another
autophagy gene associated with autoimmunity is Atg16l1, being
implicated in Crohn’s disease (CD) (Parkes et al., 2007). DCs with
patients of CD, harboring particular Atg16l1 risk variant, showed
defects in autophagy induction and in presentation and priming
of pathogen-specific CD4 T cells (Cooney et al., 2010). Interac-
tion between the gut microflora and the mucosal immune system
plays a pivotal role in CD (Manichanh et al., 2012) and autophagy
in mucosal immune cells might also influence the pathophysi-
ology and outcome of CD. Indeed, a recent report showed that
an intact autophagy pathway restricted intracellular replication of
adherent-invasive Escherichia coli, implicated in the pathogene-
sis of CD; without affecting the replication of other commensal or
pathogenic strains of E. coli involved in gastroenteritis (Lapaquette
et al., 2010).
It would be informative to determine the phenotype of mice
with autophagy deficiency in DCs, in autoimmune disease mod-
els of MS, a predominantly CD4 T cell mediated disease, or
rheumatoid arthritis.
LEVEL THREE: CYTOKINES, ER STRESS, AUTOPHAGY, AND
AUTOIMMUNITY
The third important link between autophagy and autoimmunity
could be through modulating cytokine secretion, particularly in
the context of inflammasome activation. Autophagy plays a nega-
tive role with respect to inflammasome activation and autophagy
deficiency leads to increased production of IL-1β and IL-18
(Nakahira et al., 2011; Zhou et al., 2011b). Diseases resulting
from increased activation of the immune system comprise two
different categories: autoinflammatory diseases, characterized by
inflammation mediated predominantly by innate immune cells,
including macrophages and neutrophils, and autoimmune dis-
eases in which the adaptive immune cells target the self-antigens
(McGonagle et al., 2009). The inflammasome-mediated effects
belong to the former category and the role of inflammasomes
in these diseases has been reviewed (Shaw et al., 2011). How-
ever, given the extensive effects of IL-1β on adaptive immune cells,
autophagy might also affect the outcome of autoimmune diseases
by modulating IL-1β production. As a whole, IL-1β and IL-18
enhance the functional responses of B and T cells including IL-2
receptor expression and lifespan, antibody production by B cells,
and TH1 and TH17 polarization effects (Ben-Sasson et al., 2009;
Chung et al., 2009). Thus IL-1β and IL-18 might well serve as a
bridge between autophagy in innate cells and the adaptive immune
response. In this context, IL-1β receptor blockade had beneficial
effects in rheumatoid arthritis and has been suggested as a therapy
for autoinflammatory diseases (Goldbach-Mansky, 2009). Con-
flicting reports exist regarding the role of inflammasome activation
in EAE, with one study showing roles of NLRP3 inflammasome in
EAE progression (Gris et al., 2010), whereas another study found
no such role but reported an inflammasome-independent role of
ASC (Shaw et al., 2010). The gut microbiota have important roles
in shaping the immune system as a whole and particularly in mod-
els of MS (Ivanov et al., 2009; Ochoa-Reparaz et al., 2009; Berer
et al., 2011). Given the extensive interaction between autophagy
and different microbes, it would be informative to determine how
autophagy and gut microflora interact to influence autoimmune
diseases.
Recent evidence showed that autophagy played an important
role in pancreatic beta cell functions and might modulate glu-
cose homeostasis as a whole (Ebato et al., 2008; Jung et al., 2008).
ER stress has an important role in the pathogenesis of diabetes
and autophagy plays a role in this process as well (Quan et al.,
2012). Since ER stress is involved in insulin resistance (Ozcan et al.,
2006), autophagy might also be involved in insulin resistance by
modulating ER stress response.
LEVEL FOUR: SECRETION, AUTOPHAGY, AND
AUTOIMMUNITY
Secretion from cells can proceed through two broad pathways:
a well-characterized canonical pathway in which proteins with a
signal peptide go through ER and Golgi. However, secretion of
proteins without a signal peptide proceeds through an ER-Golgi
independent pathway. Interestingly, it was proposed that secre-
tion of such proteins might, in part, be mediated by autophagy
(Giuliani et al., 2011). Autophagy-mediated secretion of acyl
coenzyme A (CoA) binding protein (ACBP), a cytosolic protein
Frontiers in Immunology | Antigen Presenting Cell Biology April 2013 | Volume 4 | Article 88 | 4
Bhattacharya and Eissa Autophagy and autoimmunity
without a signal peptide, was reported in yeasts (Duran et al.,
2010; Manjithaya et al., 2010) and recent reports also suggested
that autophagy is involved in a number of secretory processes in
immune and non-immune cells. Autophagy modulates secretory
processes in the context of osteoclastic bone formation (DeSelm
et al., 2011), from mast cells (Ushio et al., 2011), intestinal Paneth
cells (Cadwell et al., 2008), presynaptic neurotransmission (Her-
nandez et al., 2012), and secretion of IL-1β (Dupont et al., 2011).
Though the relationship between autophagy and IL-1β secretion
is complicated owing to the fact that autophagy inhibits inflam-
masome activation (Nakahira et al., 2011), a recent report showed
that baseline autophagy inhibits IL-1β secretion whereas induced
autophagy increases secretion of IL-1β (Dupont et al., 2011).
Elevated levels of type I interferon, interferon-alpha (IFN-α)
being the prototypic one, is the hallmark of SLE and clinical trials
are going on with monoclonal antibodies against IFN-α in SLE
(Lichtman et al., 2012). Interestingly, autophagy is also involved in
type I IFN secretion. Autophagy is required in plasmacytoid den-
dritic cells (pDCs), a major source of IFN-α, for sensing ssRNA
virus and secretion of IFN-α (Lee et al., 2007). Similarly mTOR
inhibition has also been shown to reduce IFN-α secretion by pDCs
in response to TLR-9 ligands (Cao et al., 2008), though whether
this is mediated by autophagy remains to be elucidated. However,
in contrast to pDCs which use Toll-like receptor 7 (TLR7) for sens-
ing ssRNA viruses, most other cell types in the body use cytosolic
RNA sensors such as RIG-I and MDA-5, belonging to the RLR fam-
ily, for this purpose. Atg5 deficiency in MEF has been shown to
increase IFN-α secretion in context of viral infections by suppress-
ing RLR signaling (Jounai et al., 2007; Tal et al., 2009). This finding
represents a non-canonical role of Atg5 (Takeshita et al., 2008; Tal
et al., 2009). Non-canonical autophagy was also shown to mediate
IFN-α secretion in response to DNA-immune complex (Henault
et al., 2012). Thus, modulation of IFN-α secretion by autophagy
pathway might play a role in SLE. In a recent study, analysis of SLE
metabolome in serum samples of SLE patients showed increased
oxidative stress (Wu et al., 2012). Autophagy deficiency is generally
associated with increased oxidative stress secondary to accumu-
lation of damaged mitochondria (Zhou et al., 2011b). On the
other hand, autophagy inhibition leads to accumulation of p62
(Mizushima and Komatsu, 2011) which, in turn, activates Nrf2
(nuclear factor erythroid 2-related factor 2) (Komatsu et al., 2007).
Nrf2 works as a major player in the oxidative stress response path-
way (Kaspar et al., 2009). The effect of modulation of autophagy
on oxidative stress of SLE warrants further studies.
It would be interesting to test how autophagy-mediated secre-
tory functions influence autoimmune processes. Though con-
sidered to be mediated by adaptive immune cells, autoimmune
processes, as in MS, are influenced by innate immune cells (Gandhi
et al., 2010). The role of autophagy in secretion might have added
significance in cells such as NK cells and neutrophils, which func-
tion mainly through secretion and degranulation. Another impor-
tant area for future exploration would be the role of autophagy in
myeloid-derived suppressor cells that suppress T cell function.
CONCLUSION
Given the above potential implications of autophagy in autoim-
munity, it is rather surprising that there are only few in vivo reports
on the functional correlation between autophagy and autoim-
mune diseases. Non-specific autophagy-lysosomal inhibitors, such
as chloroquine, have long been used in clinics to treat SLE and
rheumatoid arthritis (He et al., 2011). It is essential to understand
the complex interplay between autophagy and autoimmunity in
order to develop effective and more specific therapeutic strategies.
Autophagy might play different roles in an autoimmune disease
depending on the cell types involved and thus the ultimate results
of pharmacological modulation might depend on the downstream
effector involved. Given the paucity of in vivo data, it will be impor-
tant to determine how the findings from animal models translate
to human conditions, as pathophysiology of autoimmune diseases
vary considerably between humans and lower animals.
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